CN105209120A - 含有柠檬酸盐的饮料 - Google Patents

含有柠檬酸盐的饮料 Download PDF

Info

Publication number
CN105209120A
CN105209120A CN201480027995.9A CN201480027995A CN105209120A CN 105209120 A CN105209120 A CN 105209120A CN 201480027995 A CN201480027995 A CN 201480027995A CN 105209120 A CN105209120 A CN 105209120A
Authority
CN
China
Prior art keywords
beverage
mmol
citrate
pyridoxine
citric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480027995.9A
Other languages
English (en)
Chinese (zh)
Inventor
D·S·戈德法布
B·艾思娜
J·阿斯布林
M·L·斯托勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CALIFORNIA SENATE
General Hospital Corp
New York University NYU
Original Assignee
CALIFORNIA SENATE
General Hospital Corp
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CALIFORNIA SENATE, General Hospital Corp, New York University NYU filed Critical CALIFORNIA SENATE
Publication of CN105209120A publication Critical patent/CN105209120A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/68—Acidifying substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201480027995.9A 2013-03-15 2014-03-14 含有柠檬酸盐的饮料 Pending CN105209120A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361793442P 2013-03-15 2013-03-15
US61/793,442 2013-03-15
PCT/US2014/027736 WO2014152789A1 (en) 2013-03-15 2014-03-14 Citrate containing beverage

Publications (1)

Publication Number Publication Date
CN105209120A true CN105209120A (zh) 2015-12-30

Family

ID=51528113

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480027995.9A Pending CN105209120A (zh) 2013-03-15 2014-03-14 含有柠檬酸盐的饮料

Country Status (11)

Country Link
US (4) US9278112B2 (enExample)
EP (1) EP2983783B1 (enExample)
JP (1) JP6581564B2 (enExample)
CN (1) CN105209120A (enExample)
AU (1) AU2014236553B2 (enExample)
BR (1) BR112015023495A8 (enExample)
CA (1) CA2906907C (enExample)
HK (1) HK1219070A1 (enExample)
MX (1) MX352660B (enExample)
PH (1) PH12015502150A1 (enExample)
WO (1) WO2014152789A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108125232A (zh) * 2017-03-07 2018-06-08 浙江欣诺医药有限公司 预防与治疗泌尿系结石的补充剂及其制备方法和应用
CN108887682A (zh) * 2018-06-09 2018-11-27 夏志君 柠檬酸钠制成柠檬酸钠养生粉及其应用
CN109963575A (zh) * 2016-10-27 2019-07-02 斯蒂芬妮·A·塞克萨斯-麦克卢思 用于预防和治疗肾结石的果汁饮料
US11273140B2 (en) 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2983783B1 (en) * 2013-03-15 2021-04-21 New York University Citrate containing beverage
ES2486441B1 (es) * 2014-04-02 2015-06-11 Universitat De Les Illes Balears Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico
WO2016159897A1 (en) * 2015-04-01 2016-10-06 Ay Doğan Potassium citrate suspension
IL247130B (en) * 2015-08-06 2021-06-30 Kenneth Davin Fine A compound for blocking and absorbing oxalate for use in the treatment of pain due to fibromyalgia, calcification of the spinal cord and calcification of the shoulder
JP6714984B2 (ja) * 2015-08-31 2020-07-01 キリンビバレッジ株式会社 クエン酸由来の異味が低減された容器詰めクエン酸高含有酸性飲料
CA3015055A1 (en) 2017-08-22 2019-02-22 Ryan Holland Dietary supplementation with mixed alkali salts
US11259553B2 (en) 2017-08-22 2022-03-01 Litholyte Corporation, Llc Dietary supplementation with mixed alkali salts
PH12022552709A1 (en) * 2020-04-14 2024-04-22 Nippon Chemiphar Co Agent for improving quality of sleep

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1033349A (zh) * 1987-11-28 1989-06-14 王龙祥 可乐系列饮料的制法
US4966776A (en) * 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
CN1284303A (zh) * 2000-09-08 2001-02-21 徐华春 治疗结石的饮料
US20010002269A1 (en) * 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
US20030203072A1 (en) * 2002-04-26 2003-10-30 Team Nrg, Inc. Rehydration beverage
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
WO2012013975A1 (en) * 2010-07-27 2012-02-02 Omniceutica Limited Nutritional compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165181B (enExample) * 1971-11-08 1974-07-27
US4985593A (en) 1988-01-05 1991-01-15 Mission Pharmacal Company, Inc. Magnesium potassium citrate
US5085883A (en) * 1991-06-27 1992-02-04 Abbott Laboratories Blend of dietary fiber for nutritional products
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
BR0111292A (pt) * 2000-06-02 2003-06-10 Procter & Gamble Composições com baixo teor de carboidrato, kits destas e métodos de uso
US20050100637A1 (en) 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
US7323201B2 (en) 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
US7205018B2 (en) 2004-10-07 2007-04-17 Next Proteins, Inc. Carbonated protein drink and method of making
US7897192B2 (en) 2004-10-07 2011-03-01 Next Proteins, Inc. High energy carbonated protein drink and method of making
US20070077314A1 (en) 2005-07-15 2007-04-05 Pak Charles Y C Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
JP5349744B2 (ja) * 2005-12-19 2013-11-20 松谷化学工業株式会社 ミネラル吸収促進剤、食品及び飼料
AU2008254417B2 (en) * 2007-05-18 2013-05-30 Mjn U.S. Holdings Llc Acidified liquid human milk supplement
CA2817372A1 (en) 2010-11-18 2012-05-24 The Coca-Cola Company Performance enhancing sports beverage and methods of use
EP2983783B1 (en) * 2013-03-15 2021-04-21 New York University Citrate containing beverage

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966776A (en) * 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
CN1033349A (zh) * 1987-11-28 1989-06-14 王龙祥 可乐系列饮料的制法
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US20010002269A1 (en) * 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
CN1284303A (zh) * 2000-09-08 2001-02-21 徐华春 治疗结石的饮料
US20030203072A1 (en) * 2002-04-26 2003-10-30 Team Nrg, Inc. Rehydration beverage
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
WO2012013975A1 (en) * 2010-07-27 2012-02-02 Omniceutica Limited Nutritional compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王青豪等: "柠檬酸钾对尿石患者和正常人尿液凝胶中草酸钙晶体生长的影响", 《人工晶体学报》 *
陈宗跃等: "尿石症的相关危险因素", 《医学综述》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11273140B2 (en) 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
CN109963575A (zh) * 2016-10-27 2019-07-02 斯蒂芬妮·A·塞克萨斯-麦克卢思 用于预防和治疗肾结石的果汁饮料
CN108125232A (zh) * 2017-03-07 2018-06-08 浙江欣诺医药有限公司 预防与治疗泌尿系结石的补充剂及其制备方法和应用
CN108887682A (zh) * 2018-06-09 2018-11-27 夏志君 柠檬酸钠制成柠檬酸钠养生粉及其应用

Also Published As

Publication number Publication date
BR112015023495A2 (pt) 2017-07-18
US20140271929A1 (en) 2014-09-18
US20160184349A1 (en) 2016-06-30
JP2016513474A (ja) 2016-05-16
AU2014236553B2 (en) 2019-01-17
EP2983783A4 (en) 2016-10-26
US9895396B2 (en) 2018-02-20
EP2983783B1 (en) 2021-04-21
US9278112B2 (en) 2016-03-08
US20180169144A1 (en) 2018-06-21
EP2983783A1 (en) 2016-02-17
CA2906907C (en) 2021-04-13
MX352660B (es) 2017-12-04
US20170340664A1 (en) 2017-11-30
US10258645B2 (en) 2019-04-16
BR112015023495A8 (pt) 2019-12-03
PH12015502150A1 (en) 2016-01-25
US9737564B2 (en) 2017-08-22
AU2014236553A1 (en) 2015-11-05
WO2014152789A1 (en) 2014-09-25
CA2906907A1 (en) 2014-09-25
HK1219070A1 (zh) 2017-03-24
JP6581564B2 (ja) 2019-09-25
MX2015013221A (es) 2016-04-15

Similar Documents

Publication Publication Date Title
CN105209120A (zh) 含有柠檬酸盐的饮料
EP0912110B1 (en) Improvements in or relating to compositions containing creatine
Fairweather-Tait et al. Iron and calcium bioavailability of fortified foods and dietary supplements
CA2881076C (en) Liquid nutritional formula for phenylketonuria patients
US7063865B2 (en) Composition and method for substantially reducing the deleterious effects of alcohol on the body
US20140093609A1 (en) Nutritional compositions for enhancing performance and methods for making and using same
Latham et al. Efficacy trials of a micronutrient dietary supplement in schoolchildren and pregnant women in Tanzania
CN1826060B (zh) 认知功能的帮助
JPH0272843A (ja) 糖アルコールを含有するミネラル補給剤
WO2016205489A1 (en) Formula for management of phenylketonuria
US10986857B2 (en) Dietary supplementation with mixed alkali salts
US20090130261A1 (en) Vit-A-Cup
US20100068347A1 (en) Nutraceutical sweetener composition
US11259553B2 (en) Dietary supplementation with mixed alkali salts
EP4412625A1 (en) Compositions and methods for treating acute alcohol intake
JP2007295881A (ja) 顧客データに基づくサプリメントの調製方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1219070

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20151230

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1219070

Country of ref document: HK